Pretreatment Liver Stiffness Predicts HCC Risk Post-SVR in Hepatitis C
The following is a summary of “Long-term risk of HCC in a DAA-treated national hepatitis C cohort,...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 589 results for 'hcc'
Test Your Knowledge of HCC Presented at ASCO 2024!
Do you remember the HCC research presented at ASCO 2024? Test your knowledge and see how you rank!
Read More
ASCO 2024 eBook on HCC
A curated eBook featuring ASCO 2024 HCC-focused studies, findings, and expert opinions.
Read More
CTNNB1 Alterations Affect Outcomes in Patients With HCC
CTNNB1 alterations affect outcomes in patients with hepatocellular carcinoma (HCC).
Read More
CME/CE: In Multifocal HCC, Survival Better With Liver Resection Vs Tumor Ablation
This course discusses the overall survival with liver resection versus tumor ablation in patients...
Read More
Black Patients With HCC Less Likely to Receive Curative Treatment
Black patients with HCC are less likely than White patients to receive curative treatment.
Read More
ALBI Grade, MVI, & Distant Metastases Predict Survival in HCC
HCC survival time is predicted by albumin-bilirubin grade, microvascular invasion, and distant metastases.
Read More
Adjuvant Immunotherapy and Survival Outcomes in Intermediate/Advanced HCC
The following is a summary of “Survival outcomes with adjuvant immunotherapy after hepatic...
Read More
Phosphoproteomics Unveils AB Response in Patients with aHCC
The following is a summary of “Identification of a predictive phosphoproteomic signature of...
Read MoreAdvertisement
Precision Medicine in HCC: Unveiling Molecular Subtypes through Integrated Multi-Omics Analysis
The following is a summary of “Identification of molecular subtypes for integrated multi-omics...
Read More
Comparing Lenvatinib and Atezolizumab-Bevacizumab in Advanced HCC Treatment
The following is a summary of “Atezolizumab + bevacizumab versus lenvatinib as first-line systemic...
Read More
Targeting the Immunosuppressive Microenvironment in HCC for Enhanced Immunotherapy Efficacy
The following is a summary of “Immunosuppressive tumor microenvironment and immunotherapy of...
Read More
SBRT Effective in HCC, With “Acceptable” Liver-Related Toxicity Profile
Using stereotactic body radiation therapy for hepatocellular carcinoma with multiple lesions appears feasible, with an acceptable risk profile.
Read MorePD-1, CTLA-4 Expression May Be Prognostic Biomarkers for HCC
Programmed cell death protein 1 (PD-1) and cyto – toxic T-lymphocyte-associated protein 4 (CTLA-4) could serve as biomarkers for hepatocellular carcinoma (HCC), according to findings published in Cancers. To determine if...
Read More
In Multifocal HCC, Survival Better With Liver Resection Vs Tumor Ablation
Liver resection in patients with multifocal hepatocellular carcinoma leads to longer survival compared to tumor ablation.
Read More
Analyzing Vertical OHCC Based on Rescuer’s Handedness
The following is a summary of “Comparisons of the vertical one-handed chest compressions...
Read More
Correlation Between Sociodemographic Characteristics and Surgical Interventions for Pediatric HB and HCC
The following is a summary of “Association of Sociodemographic Factors with Surgical Management of...
Read More
Assessment of the CRAFITY Score in Advanced HCC Treated with Combination Therapy
The following is a summary of “Utility and predictive value of the CRAFITY score in advanced...
Read More
Left Hemihepatectomy Reduces Recurrence in HCC Vs Lobectomy
Left hemihepatectomy reduces early/intrahepatic recurrence in hepatocellular carcinoma near the left portal vein vs liver lobectomy, with higher 5-year survival.
Read More
CT Imaging May Be Biomarker for Predicting HCC Recurrence
CT patterns indicating aggressive growth are potential biomarkers for hepatocellular carcinoma recurrence post-liver transplant, validated by a reliable nomogram.
Read More